Lilly Covid antibodies cut hospitalizations and deaths
US pharmaceutical company Eli Lilly’s combination of two synthetic antibodies against COVID-19 reduced hospitalizations and deaths by 70 percent in
Read more
US pharmaceutical company Eli Lilly’s combination of two synthetic antibodies against COVID-19 reduced hospitalizations and deaths by 70 percent in
Read moreFox News Flash top headlines for December 8 Fox News Flash top headlines are here. Check out what’s clicking on
Read moreThe head of the U.S. Centers for Disease Control and Prevention warned Wednesday that the coming winter months might be
Read moreMONDAY, Nov. 9, 2020 — From 2003 to 2016, there was a considerable increase in drug-related endogenous endophthalmitis hospitalizations in
Read moreFox News Flash top headlines for November 11 Fox News Flash top headlines are here. Check out what’s clicking on
Read moreThe out-of-pocket financial burden for insured working Americans is substantial and growing—especially when it comes to out-of-network, non-emergency hospital care,
Read moreMaryland’s Health Enterprise Zones, state-funded initiatives designed to improve health care outcomes and prevent unnecessary hospitalizations in underserved communities, were
Read moreA phase three clinical trial has shown that a drug called tafamidis significantly reduces deaths and hospitalizations in patients with
Read more